Spero Therapeutics, Inc. logo

Spero Therapeutics, Inc.


Overview | Financials
Company Name Spero Therapeutics, Inc.
Symbol SPRO
Currency USD
Price 1.48
Market Cap 79,900,168
Dividend Yield 0%
52-week-range 0.99 - 1.89
Industry Biotechnology
Sector Healthcare
CEO Mr. Satyavrat Shukla C.F.A.
Website https://sperotherapeutics.com

An error occurred while fetching data.

About Spero Therapeutics, Inc.

Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing, and commercializing treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States. The company's product candidates include tebipenem pivoxil hydrobromide (HBr), an oral carbapenem-class antibiotic to treat complicated urinary tract infections, including pyelonephritis for adults;

Related Stocks

IN8bio, Inc. logo

IN8bio, Inc.


1.04 USD

Neoleukin Therapeutics, Inc. logo

Neoleukin Therapeutics, Inc.


3.49 USD

Cocrystal Pharma, Inc. logo

Cocrystal Pharma, Inc.


2.07 USD

Ocuphire Pharma, Inc. logo

Ocuphire Pharma, Inc.


1.71 USD


Numbers are in millions USD

Numbers are in millions USD